Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vera Popovic

Showing results (61-70 of 121) with videos related to

Pageof 13
Sort By:
Clinical Endocrinology|January 17, 2004
Evaluation of the reproducibility of the GHRH plus GHRP-6 test of growth hormone reserve in adultsVera Popovic, Sandra Pekic, Dragan Micic, et al.
Pituitary|November 1, 2011
The metabolic consequences of thyroxine replacement in adult hypopituitary patientsHelena Filipsson Nyström, Ulla Feldt-Rasmussen, Ione Kourides, et al.
European Journal of Endocrinology|November 30, 2002
Ghrelin-induced GH secretion in normal subjects is partially resistant to homologous desensitization by GH-releasing peptide-6Dragan Micic, Djura Macut, Mirjana Sumarac-Dumanovic, et al.
Clinical Endocrinology|April 6, 2005
Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure?Svetozar S Damjanovic, Aleksandar N Neskovic, Milan S Petakov, et al.
Endocrine|July 14, 2004
Retroperitoneal malignant fibrous histiocytoma mimicking pheochromocytomaSandra Pekic, Svetozar Damjanovic, Marina Djurovic, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 2, 2013
Chronic risperidone exposure does not show any evidence of bone mass deterioration in animal model of schizophreniaNatasa Petronijevic, Jelena Sopta, Mirjana Doknic, et al.
European Journal of Endocrinology|March 23, 2023
Initial pathology in aggressive pituitary tumours and carcinomas: 2b or not 2b?-that is the questionJacqueline Trouillas, Pia Burman, Marco Losa, et al.
European Journal of Endocrinology|August 26, 2022
Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patientsPia Burman, Jacqueline Trouillas, Marco Losa, et al.
Hormones (Athens, Greece)|September 28, 2006
The influence of serum cortisol levels on growth hormone responsiveness to GH-releasing hormone plus GH-releasing peptide-6 in patients with hypocortisolismSandra Pekic, Mirjana Doknic, Marina Djurovic, et al.
Pituitary|May 4, 2016
Giant prolactinomas larger than 60 mm in size: a cohort of massive and aggressive prolactin-secreting pituitary adenomasIlan Shimon, Ernesto Sosa, Victoria Mendoza, et al.
Pageof 13

Showing results (61-70 of 121) with videos related to

Sort By:
Pageof 13
Clinical Endocrinology|January 17, 2004
Evaluation of the reproducibility of the GHRH plus GHRP-6 test of growth hormone reserve in adultsVera Popovic, Sandra Pekic, Dragan Micic, et al.
Pituitary|November 1, 2011
The metabolic consequences of thyroxine replacement in adult hypopituitary patientsHelena Filipsson Nyström, Ulla Feldt-Rasmussen, Ione Kourides, et al.
European Journal of Endocrinology|November 30, 2002
Ghrelin-induced GH secretion in normal subjects is partially resistant to homologous desensitization by GH-releasing peptide-6Dragan Micic, Djura Macut, Mirjana Sumarac-Dumanovic, et al.
Clinical Endocrinology|April 6, 2005
Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure?Svetozar S Damjanovic, Aleksandar N Neskovic, Milan S Petakov, et al.
Endocrine|July 14, 2004
Retroperitoneal malignant fibrous histiocytoma mimicking pheochromocytomaSandra Pekic, Svetozar Damjanovic, Marina Djurovic, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 2, 2013
Chronic risperidone exposure does not show any evidence of bone mass deterioration in animal model of schizophreniaNatasa Petronijevic, Jelena Sopta, Mirjana Doknic, et al.
European Journal of Endocrinology|March 23, 2023
Initial pathology in aggressive pituitary tumours and carcinomas: 2b or not 2b?-that is the questionJacqueline Trouillas, Pia Burman, Marco Losa, et al.
European Journal of Endocrinology|August 26, 2022
Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patientsPia Burman, Jacqueline Trouillas, Marco Losa, et al.
Hormones (Athens, Greece)|September 28, 2006
The influence of serum cortisol levels on growth hormone responsiveness to GH-releasing hormone plus GH-releasing peptide-6 in patients with hypocortisolismSandra Pekic, Mirjana Doknic, Marina Djurovic, et al.
Pituitary|May 4, 2016
Giant prolactinomas larger than 60 mm in size: a cohort of massive and aggressive prolactin-secreting pituitary adenomasIlan Shimon, Ernesto Sosa, Victoria Mendoza, et al.
Pageof 13